A low ferritin pregnancy result can mean your iron stores are running low, even if your haemoglobin is still within range. Ferritin helps clinicians assess stored iron, while a blood count measures haemoglobin and can show whether anaemia has developed. The tests answer related but different questions, so one result alone may not tell the whole story.
What Low Ferritin Pregnancy Results Can Mean
Pregnancy increases the body’s demand for iron. A 2017 clinical review by Christian Breymann, Christoph Honegger, Ivo Hösli and Daniel Surbek describes serum ferritin below 30 micrograms per litre (μg/L) as a threshold for iron deficiency in pregnancy. That is a commonly used clinical threshold, not a stand-alone diagnosis: your clinician interprets it alongside your blood count, pregnancy stage and health history.
Low ferritin with normal haemoglobin points to depleted stores without anaemia. If haemoglobin is also low, you may have iron-deficiency anaemia—but low haemoglobin can have other causes, so further assessment may be needed. Ruramayi Rukuni and colleagues’ 2015 structured review of screening evidence against UK National Screening Committee criteria found that haemoglobin and ferritin were suitable tests, but that the clinical consequences of iron deficiency without anaemia were not established. That uncertainty matters: a low ferritin result deserves discussion, but it does not by itself predict a particular outcome.
Screening And Thresholds Vary By Region
Pregnancy testing pathways are not identical worldwide. Rukuni’s review described UK practice at the time as checking haemoglobin at the booking appointment and again at 28 weeks, while routine ferritin testing for every pregnant person was not recommended in the guidance it reviewed. Ferritin could be considered for people at higher risk or when knowing iron stores would affect care. These are historical UK recommendations, not a universal schedule or a substitute for checking current local guidance.
Some UK guidance summarized in that review used haemoglobin below 110 g/L in the first trimester and below 105 g/L later in pregnancy as thresholds for investigating anaemia. A result should still be interpreted using the reference ranges and pathway your maternity team follows. If you are in the US, EU or Australia, ask which blood tests are routine where you receive care and whether your risk factors or results call for ferritin testing. There is no single international testing schedule to assume.
What To Expect From Oral Iron
When iron deficiency or iron-deficiency anaemia is identified, oral iron is generally the first treatment considered. The prescribed preparation and amount depend on your circumstances; follow your clinician’s directions rather than adding extra iron on your own. Iron tablets can cause gastrointestinal side effects. If nausea, constipation or another problem makes them hard to take, tell your care team instead of silently stopping treatment. They can review how you are taking it and whether another approach is appropriate.
Follow-up is part of treatment. UK guidance summarized in the 2015 review used a rise in haemoglobin after two weeks of oral iron as evidence supporting iron deficiency in certain cases of anaemia. If haemoglobin does not improve, that does not automatically mean you need an infusion: clinicians may check how consistently the tablets are being taken, whether iron is being absorbed and whether another cause needs investigation. Ask when your next blood test is planned and what response your team expects.
When Intravenous Iron May Be Considered
An infusion may be discussed when anaemia is severe, oral iron is not tolerated or absorbed, treatment has not worked, or there is a clinical need to correct anaemia more quickly—for example, later in pregnancy. The timing and suitability depend on your situation and local guidance; the UK guidance summarized by Rukuni and colleagues considered intravenous iron from the second trimester in specific circumstances.
A systematic review of randomized trials in pregnant people with confirmed iron-deficiency anaemia compared intravenous with oral iron. Across 11 trials and 2,935 participants, intravenous iron probably raised haemoglobin slightly more at three to six weeks: about 0.49 g/dL (4.9 g/L) on average. This supports a faster improvement in blood results for some patients; it does not establish that an infusion is needed for everyone or guarantee better outcomes for mother or baby. Intravenous iron is given under medical supervision, and the 2017 clinical review recommends close monitoring during administration.
If your result is low, ask your clinician what it means alongside your haemoglobin, whether ferritin was measured, when to repeat blood tests and what the next step would be if tablets are difficult or your results do not improve. Seek advice from your maternity or medical team about your own results and treatment options; this guide cannot determine what is right for an individual pregnancy.